Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland · Delayed Price · Currency is CHF
17.60
+0.30 (1.73%)
May 13, 2026, 5:31 PM CET
Revenue by Segment
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Development and Commercialization of products for the treatment of Neuromuscular and Pulmonary Diseases | 77.19M | 39.12M | 103.41M | 7.47M | -1.60M | | | | | |
Development and Commercialization of products for the treatment of Neuromuscular and Pulmonary Diseases Growth | 97.32% | -62.17% | 1283.84% | - | - | | | | | |
| 77.19M | 39.12M | 103.41M | 7.47M | -1.60M | | | | | |
| 97.32% | -62.17% | 1283.84% | - | - | | | | | |
Revenue by Geography
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 6.52M | 12.79M | 1.92M | 11.19M | - | | | | | |
| -49.02% | 565.96% | -82.83% | - | - | | | | | |
| 46.29M | 11.35M | 98.09M | - | - | | | | | |
| 307.67% | -88.43% | - | - | - | | | | | |
| 24.38M | 14.97M | 3.40M | -3.72M | -1.60M | | | | | |
| 62.83% | 340.04% | - | - | - | | | | | |
| 77.19M | 39.12M | 103.41M | 7.47M | -1.60M | | | | | |
| 97.32% | -62.17% | 1283.84% | - | - | | | | | |
Source: S&P Global Market Intelligence.
